Finally, STAT3 activation in tumor cells impairs the migration of virtually every component of the immune response to the tumor microenvironment, such that responding cells cannot reach the site of the cancer; targeting STAT3 in tumors alters their cytokine/growth factor profile, resulting in increased migration to microenvironment and potentially enhancing antigen presentation and immune effector functions. The gene discussed is STAT3; the disease is cancer.